Advertisement
Research
Oral food challenges are the clinical standard for diagnosis of food allergy. Little data exist on predictors of oral challenge failure and reaction severity.
Allergy, Asthma & Clinical Immunology 2017 13:43
Published on: 22 September 2017
Case Report
Allergic, especially anaphylactic, reactions during immunoglobulin replacement therapy are rare, but their pathophysiology and classification remain ambiguous. Recent findings show positive results of skin tes...
Allergy, Asthma & Clinical Immunology 2017 13:41
Published on: 15 September 2017
Research
The prevalence of adverse food reactions (AFR) has been increasing in the western world. Clinical manifestations are diversified and it may not be possible to clinically discriminate between IgE and non-IgE me...
Allergy, Asthma & Clinical Immunology 2017 13:40
Published on: 6 September 2017
Case report
Omalizumab is a human IgG1 antibody against IgE used as a therapy for sever asthmatic patients with asthma. According to the guidelines of the Global Initiative for Asthma, omalizumab is an add-on drug at trea...
Allergy, Asthma & Clinical Immunology 2017 13:39
Published on: 31 August 2017
Short Report
Treat-to-target therapy approaches are established for chronic diseases such as diabetes, hypertension, and more recently rheumatoid arthritis, resulting in improved patient outcomes. These approaches do not u...
Allergy, Asthma & Clinical Immunology 2017 13:38
Published on: 24 August 2017
Research
Sleep disorders are often underreported to physicians by patients with allergies. This study aimed to characterize the sleep disorders associated with respiratory allergy to house dust mites (HDM) at the time ...
Allergy, Asthma & Clinical Immunology 2017 13:36
Published on: 16 August 2017
Research
To evaluate barrier protective properties of Rhinosectan® spray, a medical device containing xyloglucan, on nasal epithelial cells (MucilAir).
Allergy, Asthma & Clinical Immunology 2017 13:37
Published on: 10 August 2017
Research
Intelectin-1 (ITLN-1) is secreted by intestinal goblet cells and detectable in blood. Its expression is increased in IL-13-overexpressing mouse airways. However, its expression and function in human airways is...
Allergy, Asthma & Clinical Immunology 2017 13:35
Published on: 1 August 2017
Research
Omalizumab is licensed as add-on therapy for patients with severe allergic asthma. Response is in most studies scored by the physician’s global evaluation of treatment effectiveness (GETE). A good clinical and...
Allergy, Asthma & Clinical Immunology 2017 13:34
Published on: 26 July 2017
Research
There is a paucity of studies examining the safety of venom immunotherapy (VIT) in children. We aimed to assess the incidence of anaphylactic side effects during rush VIT in a cohort of pediatric patients and ...
Allergy, Asthma & Clinical Immunology 2017 13:32
Published on: 12 July 2017
Erratum
Allergy, Asthma & Clinical Immunology 2017 13:33
Published on: 7 July 2017
The original article was published in Allergy, Asthma & Clinical Immunology 2016 12:11
Research
Patients with hereditary angioedema (HAE) due to C1-inhibitor deficiency (C1-INH-HAE) experience recurrent attacks of cutaneous or submucosal edema that may be frequent and severe; prophylactic treatments can ...
Allergy, Asthma & Clinical Immunology 2017 13:31
Published on: 5 July 2017
Research
Current pressurised metered dose asthma inhaler (pMDI) propellants are not inert pharmacologically as were previous chlorofluorocarbons, have smooth muscle relaxant‚ partial pressure effects in the lungs and i...
Allergy, Asthma & Clinical Immunology 2017 13:30
Published on: 29 June 2017
Meeting abstracts
Allergy, Asthma & Clinical Immunology 2017 13(Suppl 2):29
Published on: 15 June 2017
This article is part of a Supplement: Volume 13 Supplement 2
Short Report
Angioedema without co-existent urticaria is due to a limited number of causes, including hereditary and acquired C1 esterase inhibitor deficiency, drug-induced angioedema or idiopathic histaminergic or non-his...
Allergy, Asthma & Clinical Immunology 2017 13:28
Published on: 13 June 2017
Research
Asthma is an independent risk factor for invasive pneumococcal disease; however, the immune response of adult asthma patients to pneumococcal vaccination is unknown. We explore the serologic response of patien...
Allergy, Asthma & Clinical Immunology 2017 13:27
Published on: 7 June 2017
Research
Many studies have identified associations between qualities of maternal–child relationships and childhood asthma, but few have examined associations with childhood atopic dermatitis (AD), a common precursor to...
Allergy, Asthma & Clinical Immunology 2017 13:26
Published on: 26 May 2017
Research
Up-regulation of interleukin 17 (IL-17) family cytokines and acute phase response have been observed in patients with chronic spontaneous urticaria (CSU). It has been demonstrated that IL-17 stimulates C-react...
Allergy, Asthma & Clinical Immunology 2017 13:25
Published on: 10 May 2017
Research
Success in asthma management hinges on patients’ competency to detect and respond to ever-changing symptom severity. Thus, it is crucial to have reliable, simple, and sustainable methods of symptom monitoring ...
Allergy, Asthma & Clinical Immunology 2017 13:24
Published on: 28 April 2017
Case Report
Mastocytosis are rare diseases characterized by an accumulation of clonal mast cells (MCs) in one or multiple organs or tissues. Patients with systemic mastocytosis (SM), whose MCs frequently arbor the activat...
Allergy, Asthma & Clinical Immunology 2017 13:21
Published on: 24 April 2017
Research
The mechanisms through which allergies can be inhibited after preconception immunization with allergens are not fully understood. We aimed to evaluate whether maternal immunization can induce a regulatory B (B...
Allergy, Asthma & Clinical Immunology 2017 13:22
Published on: 17 April 2017
Research
Interleukin-31 (IL-31) is a recently identified cytokine produced by Th2 cells that is involved in the development of atopic dermatitis-induced skin inflammation and pruritus. Its receptor, IL-31RA, is express...
Allergy, Asthma & Clinical Immunology 2017 13:23
Published on: 17 April 2017
Meeting abstracts
Allergy, Asthma & Clinical Immunology 2017 13(Suppl 1):16
Published on: 7 April 2017
This article is part of a Supplement: Volume 13 Supplement 1
Research
Prednisone dependence in asthma is usually described based on clinical and spirometric characteristics. It is generally believed that these patients have frequent exacerbations and lose lung function rapidly b...
Allergy, Asthma & Clinical Immunology 2017 13:17
Published on: 4 April 2017
Research
Nasal nitrous oxide (nNO) is increased in allergic rhinitis (AR), but not in asthma, and is a non-invasive marker for inflammation in the nasal passages.
Allergy, Asthma & Clinical Immunology 2017 13:20
Published on: 4 April 2017
The official journal of CSACI
Advertisement
